MoonLake Reports Strong One-Year Phase 3 Results f...
Category : Clinical Trial Update 24 June 2026MoonLake Immunotherapeutics has announced positive Week 52 results from its Phase 3 VELA-1 and VELA-...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
CureGene Doses First Patient in US Pivotal Trial o...
Category : Clinical Trial Update 24 June 2026CureGene Pharmaceutical has announced that the first participant has been successfully dosed in the...
Agomab Unveils Phase 2b Study Design for Ontuniser...
Category : Clinical Trial Update 24 June 2026Agomab Therapeutics has announced the design of its upcoming Phase 2b NOV-ERA clinical trial for ont...
AbbVie to Acquire Apogee Therapeutics in $10.9 Bil...
Category : Merger/Acquisition 23 June 2026AbbVie and Apogee Therapeutics have announced a definitive agreement under which AbbVie will acquire...
uniQure Reports Early Clinical Data for Gene Thera...
Category : Clinical Trial Update 23 June 2026uniQure NV has announced initial six-month follow-up results from the first patient group enrolled i...
Latest Newsletter Post
-
Agomab Unveils Phase 2b Study Desig..
24 June 2026
-
CureGene Doses First Patient in US..
24 June 2026
-
MoonLake Reports Strong One-Year Ph..
24 June 2026
-
uniQure Reports Early Clinical Data..
23 June 2026
-
AbbVie to Acquire Apogee Therapeuti..
23 June 2026
